Provided are liquid ready to use formulations of dexmedetomidine. Preferably the formulations comprise between 0.05 micrograms/mL and 15 micrograms/mL of dexmedetomidine, are stored in sealed glass containers and can be administered without dilution. Dexmedetomidine has analgesic and sedative activity.